beth israel deaconess medical center a harvard medical school teaching hospital

To find a doctor, call 800-667-5356 or click below:

Find a Doctor

Request an Appointment

left banner
right banner
  • Home
  • News
  • In Research
  • > Stuart Schnitt, MD, Becomes President of U.S. & Canadian Academy of Pathology
Smaller Larger

Stuart Schnitt, MD, Becomes President of U.S. & Canadian Academy of Pathology

BIDMC's Director of Anatomic Pathology will lead 11,000-member academy

BOSTON -- Stuart Schnitt, MD, Director of Anatomic Pathology at Beth Israel Deaconess Medical Center (BIDMC) and an internationally recognized expert in breast cancer pathology, was inducted as president of the United States & Canadian Academy of Pathology (USCAP) on April 1.

The USCAP has nearly 11,000 physician pathologist members worldwide and is the largest of 54 divisions of the International Academy of Pathology. In partnership with the Nature Publishing Group, the USCAP publishes two major scientific pathology journals, Laboratory Investigation and Modern Pathology.

"It is truly an honor to serve as president of the USCAP," says Schnitt. "This organization does so much for the advancement of diagnostic anatomic and molecular pathology, and is the greatest forum in the world to foster pathology innovation and career development. I owe so much of my career success to USCAP."

A leader in breast cancer and benign breast disease pathology, Schnitt is also a Professor of Pathology at Harvard Medical School. His research interests have primarily focused on risk factors for local recurrence in patients with invasive breast cancer and ductal carcinoma in situ treated with breast conserving therapy, benign breast disease and breast cancer risk, and stromal-epithelial interactions in breast tumor progression.

"Stuart Schnitt's contributions at BIDMC have helped make our program a world leader in diagnostic surgical pathology and have played a crucial role in optimizing the care of cancer patients," notes Jeffrey Saffitz, MD, PhD, Chairman of Pathology at BIDMC. "We are privileged to have Dr. Schnitt on our team and know that through his innovative thinking and vision, he will bring to the USCAP the same distinguished leadership he has provided to our institution."

Schnitt completed his internship and residency in Anatomic and Clinical Pathology at Boston's former Beth Israel (BI) Hospital, followed by a fellowship in surgical pathology, also at the former BI. He joined Beth Israel's Pathology staff in 1984.

Schnitt has published more than 240 articles, editorials and book chapters, primarily in the area of breast diseases. He is also the coauthor of the widely used textbook Biopsy Interpretation of the Breast, published in 2009. He currently serves on the editorial boards of 13 journals. He is the 1999 recipient of the Arthur Purdy Stout Society of Surgical pathologists Annual Prize and the Golden Microscope Award for Resident Teaching and Mentoring at BIDMC.

Beth Israel Deaconess Medical Center (BIDMC) is a patient care, teaching and research affiliate of Harvard Medical School, and consistently ranks in the top four in National Institutes of Health funding among independent hospitals nationwide. BIDMC is a clinical partner of the Joslin Diabetes Center and a research partner of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.

RELATED LINKS